Patents by Inventor Henry W. Lopez

Henry W. Lopez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190071470
    Abstract: Aspects of the present invention relate to peptides having antimicrobial activity. In certain aspects, the invention relates to peptides having potent antimicrobial activity, broad-spectrum antimicrobial activity, and/or the ability to kill otherwise antibiotic-resistant microbes, or microbes protected by biofilms.
    Type: Application
    Filed: June 5, 2018
    Publication date: March 7, 2019
    Inventors: Jesse Jaynes, L. Edward Clemens, Henry W. Lopez, George R. Martin, Kathryn Woodburn
  • Patent number: 10016480
    Abstract: Methods for treating a subject for pancreatic cancer via administration of small anti-inflammatory peptides are disclosed. The peptides may be administered in conjunction with another therapeutic agent, such as a chemotherapeutic agent, or therapeutic regimen. In some cases, the anti-inflammatory peptide that finds use in the subject methods has the amino acid sequence Lys-Phe-Arg-Lys-Ala-Phe-Lys-Arg-Phe-Phe (SEQ ID NO:1) or a multimer, derivative, or variant thereof.
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: July 10, 2018
    Assignees: The United States of America, as Represented by the Secretary, Dept. of Health and Human Services, Riptide Bioscience, Inc.
    Inventors: Udo Rudloff, Jesse M. Jaynes, Henry W. Lopez, George R. Martin, Clayton Yates
  • Patent number: 10017542
    Abstract: Aspects of the present invention relate to peptides having antimicrobial activity. In certain aspects, the invention relates to peptides having potent antimicrobial activity, broad-spectrum antimicrobial activity, and/or the ability to kill otherwise antibiotic-resistant microbes, or microbes protected by biofilms.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: July 10, 2018
    Assignee: Riptide Bioscience, Inc.
    Inventors: Jesse Jaynes, L. Edward Clemens, Henry W. Lopez, George R. Martin, Kathryn Woodburn
  • Publication number: 20170252396
    Abstract: Methods for treating pancreatic cancer via administration of small anti-inflammatory peptides. The peptides may be administered in conjunction with another therapeutic agent or therapeutic regimen.
    Type: Application
    Filed: October 13, 2015
    Publication date: September 7, 2017
    Applicants: The United States of America, as represented by the Secretary, Department of Health and Human Serv, Riptide Bioscience, Inc.
    Inventors: Udo Rudloff, Jesse M. Jaynes, Henry W. Lopez, George R. Martin, Clayton Yates
  • Patent number: 9492499
    Abstract: Aspects of the present invention relate to peptides having anti-inflammatory activity, compositions containing one or more of the peptides, and use of the peptides to treat conditions associated with excessive inflammation in animals, particularly humans and other mammals.
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: November 15, 2016
    Assignee: Riptide Bioscience, Inc.
    Inventors: Jesse M. Jaynes, Henry W. Lopez, George R. Martin, Clayton Yates, Charles E. Garvin
  • Publication number: 20160296594
    Abstract: Aspects of the present invention relate to peptides having antimicrobial activity. In certain aspects, the invention relates to peptides having potent antimicrobial activity, broad-spectrum antimicrobial activity, and/or the ability to kill otherwise antibiotic-resistant microbes, or microbes protected by biofilms.
    Type: Application
    Filed: March 23, 2016
    Publication date: October 13, 2016
    Inventors: Jesse Jaynes, L. Edward Clemens, Henry W. Lopez, George R. Martin
  • Publication number: 20160101150
    Abstract: Aspects of the present invention relate to peptides having anti-inflammatory activity, compositions containing one or more of the peptides, and use of the peptides to treat conditions associated with excessive inflammation in animals, particularly humans and other mammals.
    Type: Application
    Filed: October 13, 2015
    Publication date: April 14, 2016
    Inventors: Jesse M. Jaynes, Henry W. Lopez, George R. Martin, Clayton Yates, Charles E. Garvin